Management of hepatocellular carcinoma presenting as obstructive jaundice

Wan yee Lau, Joseph Leung, Arthur K C Li

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

Eleven (3%) of 340 patients with hepatocellular carcinoma (HCC) presented with obstructive jaundice. The tumor extensively infiltrated the major bile ducts in eight patients. Jaundice was relieved by endoscopic endoprosthesis in four patients, nasobiliary drainage in two patients, percutaneous transhepatic stenting in one patient, and surgical intubation in one patient. The survival interval of these eight patients (mean±SD) was 35±20 days. Three patients had tumor fragments in the common bile ducts. In two patients, major hepatic resection was done after initial tube decomposition of the biliary system. One patient remained tumor-free on follow-up at 24 months, and the other patient had recurrent tumor detected on follow-up at 17 moths after surgery. The tumor was irresectable in the third patient. Multiple surgical and endoscopic procedures kept the bile duct patent for 17 months before the patient died of the disease. Not all patients who present with obstructive jaundice due to HCC are terminally ill. With proper management, good palliation and occasional cure are possible.

Original languageEnglish (US)
Pages (from-to)280-282
Number of pages3
JournalThe American Journal of Surgery
Volume160
Issue number3
DOIs
StatePublished - 1990
Externally publishedYes

Fingerprint

Obstructive Jaundice
Hepatocellular Carcinoma
Neoplasms
Bile Ducts
Terminally Ill
Moths
Common Bile Duct
Biliary Tract
Jaundice
Intubation
Endoscopy
Drainage

ASJC Scopus subject areas

  • Surgery

Cite this

Management of hepatocellular carcinoma presenting as obstructive jaundice. / Lau, Wan yee; Leung, Joseph; Li, Arthur K C.

In: The American Journal of Surgery, Vol. 160, No. 3, 1990, p. 280-282.

Research output: Contribution to journalArticle

@article{b7473b2af8da4baa86cab19efd9c46c3,
title = "Management of hepatocellular carcinoma presenting as obstructive jaundice",
abstract = "Eleven (3{\%}) of 340 patients with hepatocellular carcinoma (HCC) presented with obstructive jaundice. The tumor extensively infiltrated the major bile ducts in eight patients. Jaundice was relieved by endoscopic endoprosthesis in four patients, nasobiliary drainage in two patients, percutaneous transhepatic stenting in one patient, and surgical intubation in one patient. The survival interval of these eight patients (mean±SD) was 35±20 days. Three patients had tumor fragments in the common bile ducts. In two patients, major hepatic resection was done after initial tube decomposition of the biliary system. One patient remained tumor-free on follow-up at 24 months, and the other patient had recurrent tumor detected on follow-up at 17 moths after surgery. The tumor was irresectable in the third patient. Multiple surgical and endoscopic procedures kept the bile duct patent for 17 months before the patient died of the disease. Not all patients who present with obstructive jaundice due to HCC are terminally ill. With proper management, good palliation and occasional cure are possible.",
author = "Lau, {Wan yee} and Joseph Leung and Li, {Arthur K C}",
year = "1990",
doi = "10.1016/S0002-9610(06)80023-1",
language = "English (US)",
volume = "160",
pages = "280--282",
journal = "American Journal of Surgery",
issn = "0002-9610",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Management of hepatocellular carcinoma presenting as obstructive jaundice

AU - Lau, Wan yee

AU - Leung, Joseph

AU - Li, Arthur K C

PY - 1990

Y1 - 1990

N2 - Eleven (3%) of 340 patients with hepatocellular carcinoma (HCC) presented with obstructive jaundice. The tumor extensively infiltrated the major bile ducts in eight patients. Jaundice was relieved by endoscopic endoprosthesis in four patients, nasobiliary drainage in two patients, percutaneous transhepatic stenting in one patient, and surgical intubation in one patient. The survival interval of these eight patients (mean±SD) was 35±20 days. Three patients had tumor fragments in the common bile ducts. In two patients, major hepatic resection was done after initial tube decomposition of the biliary system. One patient remained tumor-free on follow-up at 24 months, and the other patient had recurrent tumor detected on follow-up at 17 moths after surgery. The tumor was irresectable in the third patient. Multiple surgical and endoscopic procedures kept the bile duct patent for 17 months before the patient died of the disease. Not all patients who present with obstructive jaundice due to HCC are terminally ill. With proper management, good palliation and occasional cure are possible.

AB - Eleven (3%) of 340 patients with hepatocellular carcinoma (HCC) presented with obstructive jaundice. The tumor extensively infiltrated the major bile ducts in eight patients. Jaundice was relieved by endoscopic endoprosthesis in four patients, nasobiliary drainage in two patients, percutaneous transhepatic stenting in one patient, and surgical intubation in one patient. The survival interval of these eight patients (mean±SD) was 35±20 days. Three patients had tumor fragments in the common bile ducts. In two patients, major hepatic resection was done after initial tube decomposition of the biliary system. One patient remained tumor-free on follow-up at 24 months, and the other patient had recurrent tumor detected on follow-up at 17 moths after surgery. The tumor was irresectable in the third patient. Multiple surgical and endoscopic procedures kept the bile duct patent for 17 months before the patient died of the disease. Not all patients who present with obstructive jaundice due to HCC are terminally ill. With proper management, good palliation and occasional cure are possible.

UR - http://www.scopus.com/inward/record.url?scp=0025072163&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025072163&partnerID=8YFLogxK

U2 - 10.1016/S0002-9610(06)80023-1

DO - 10.1016/S0002-9610(06)80023-1

M3 - Article

C2 - 2168129

AN - SCOPUS:0025072163

VL - 160

SP - 280

EP - 282

JO - American Journal of Surgery

JF - American Journal of Surgery

SN - 0002-9610

IS - 3

ER -